Beijing, Taiwan

Qi-Cheng Fang


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qi-Cheng Fang: Pioneering Innovator and Problem-Solver

Introduction:

Qi-Cheng Fang is a groundbreaking inventor whose dedication to innovation and remarkable problem-solving skills have positioned him as a trailblazer in the world of inventors. Based in Beijing, TW, Fang's work continues to inspire future generations to push the boundaries of what is possible.

Latest Patents:

Fang holds one patent for Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell, which includes compounds like .alpha. boswelic acid and its acetate, .beta.-boswellic acid and its acetate. These compounds exhibit an inhibitory effect on topoisomerase I and topoisomerase II, offering potential treatment options for various cancers in mammals.

Career Highlights:

Fang is associated with the Research Triangle Institute, where he has showcased his exceptional skills in research and development. His work on innovative compounds demonstrates his commitment to advancing medical science and improving treatment outcomes for patients battling cancer.

Collaborations:

Throughout his career, Fang has collaborated closely with esteemed colleagues such as Yue-Wei Lee and Zhen-Guo Wang. Together, they have contributed significantly to the field of pharmaceutical research, harnessing their collective expertise to drive innovation and discovery.

Conclusion:

In conclusion, Qi-Cheng Fang's contributions to the field of inventors are truly exceptional. His relentless pursuit of innovation and problem-solving, coupled with his groundbreaking patents, testify to his status as a visionary inventor. Fang's work not only leaves a lasting impact on the industry but also serves as a source of inspiration for aspiring inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…